Globavir Biosciences

Globavir Biosciences

A biopharmaceutical company creating novel therapeutics and diagnostic tool for treating infectious disease.

Edit ID  18858922 

Neelam Jhaveri
Neelam Jhaveri approved a suggestion from Golden's AI on 14 Jul, 2020
Edits made to:
Article (+6/-6 characters)

On January 21, 2015 Globavir Biosciences announced raising $4 million in venture funding from StartXStartX, Stanford University Venture Fund, and Sorrento Therapeutics.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.